News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Amneal Pharmaceuticals Launches Escitalopram Oxalate Oral Solution


3/15/2012 6:47:26 AM

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, LLC today announced the launch of Escitalopram Oxalate Oral Solution in 5 mg/5 mL strength, the first generic in liquid form on the market. Amneal’s product is a therapeutically equivalent alternative to Lexapro® (a registered trademark of Forest Laboratories, Inc.). Annual U.S. sales of Lexapro Oral Solution are $7.3 million according to December 2011 IMS Health market data.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES